secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEKTAR THERAPEUTICS (NKTR)
CIK:        0000906709
Form:       8-K
Filed at:   2026-04-20T23:59:59+00:00
Accession:  0001193125-26-164186
Event type: other_material
Sentiment:  positive
Materiality: 0.55
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Nektar reports estimated cash and investments of $741.7M as of April 1, 2026
----------------------------------------------------------------------------

- Cash and marketable securities estimated at $741.7 million as of April 1, 2026.
- Announcement is a preliminary estimate, not a comprehensive financial statement.
- Amount based solely on information available as of April 20, 2026 filing date.
- No other financial results or guidance provided in the release.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/906709/000119312526164186/0001193125-26-164186-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/906709/000119312526164186/d136533d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-164186

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer